A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris

Summary

The purpose of this study is to assess the safety and tolerability of parsaclisib in participants with mild to moderate pemphigus vulgaris.

Timeline

Start

2019-03

Primary completion

2020-11

Completion

2020-11

Outcome

Outcome not reported

Stopped: “The study was withdrawn due to insufficient interest in study participation due to recent approval in this rare condition.”

Drugs

Indications